Dec 10, 2018, 2:00 am EST Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers

Press/Media

Period10 Dec 2018

Media coverage

6

Media coverage